10 Live Notices for Evolocumab Tenders
Showing 1 to 10
Drug Acquisition, For Exemption From Bidding, For The Purpose Of Complying With Judicial Decisions Given, In The Face Of The State Of Rio Grande Do Norte: Atropine Sulfate, Dosage: 0.5 % Mg/Ml, Use: Ophthalmic Solution X 5 Ml; Enzyme, Type: Alpha Glycosidase, 50 Mg Po Liof Solo Inj Iv Ct Fa V Vd Trans Trans Type Or Equivalent; Evolocumab, Concentration: 140 Mg, Ml, Pharmaceutical Form: Injectable Solution, Additional: C, Applicator Pen - Repatha. *
27 May 2025
06 Jun 2025Judicial Acquisition Of Medicines: Evolocumab
Evolocumab Suministro (Doe) And Apremilast (Doe)
Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Evolocumab - Vv83
Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Evolocumab - Vv83
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Evolocumab, Atc C10Ax13 For The Period 01.04.2025 - 31.03.2027
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Evolocumab, Atc C10Ax13 For The Period 01.04.2025 - 31.03.2027
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Inj Cangrelor 50 Mg Or Vial , Inj Evolocumab 140 Mg , Injnicorandil 2 Mg , Nbutyl Cyanoacrylate 0.5Ml Inj , Siliconspray , Disinfectant Spray 1Propanol 6Gper100G Plus2Propanol 9Gper100G Plus Ethanol 10Gper100G Microscopesurface Disinfectant Spray Eg Bacillol25 , Mesalazine 5 Asaenema 1Gmper100Ml , Pancreatin Minimicrosphere Smartdevice 30 Gm , Tab Velpatasvir 100 Mg Plussofosbuvir 400Mg , Inj Ocreluzumab 300 Mgper 10 Ml Quantity: 5133
Evolocumab 140Mg/Ml Pfs
Tenders by Country